Openspace to name two senior members, invest in Biofourmis
Biofourmis has just raised US$100 million in a series C round led by SoftBank Vision Fund 2. Source link
Below-the-radar Japanese startups with the biggest piles of cash and the Indian edtech startup that recently joined the unicorn club…
This adds to Biofourmis’ therapeutics portfolio, which includes areas such as heart failure and chronic pain. Source link
Biofourmis plans to advance its proprietary therapeutics platform and grow its US and Singapore teams to more than 100 employees….